GSK still in talks about submitting cervical cancer vaccine

01/3/2006 | ABC News

GlaxoSmithKline, seen as trailing rival Merck in getting a cervical cancer vaccine to market, said it still is in talks with the FDA about submitting its drug Cervarix for approval. GSK had been expected to announce a filing timetable before the end of 2005, while Merck's Gardasil already has been submitted to U.S. and European regulators.

View Full Article in:

ABC News

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Principal Engineer - Service (US/MI/00/0043/SL) - 14000009CP
Abbott
Chicago, IL
Senior Manager, Compliance
Stryker
Fremont, CA
Manager, Business Conduct
Gilead
Foster City, CA
Product Patent Attorney
Gilead
Foster City, CA
Employment Counsel
Gilead
Foster City, CA